Citigroup
SPTX

Citigroup’s Seaport Therapeutics SPTX Stock Holding History

Citigroup’s Portfolio SPTX Stock Details SPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.3K Buy
+2,454
New +$43.2K ﹤0.01% 4953

Other funds holding SPTX

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Citigroup's SPTX Position: Q2 2026 in Review

Citigroup opened a new position in Seaport Therapeutics (SPTX) in Q2 2026: 2,454 shares worth $53.3K. The stake represents ﹤0.01% of the portfolio and ranks #4953 among its holdings.

5 funds tracked by Wall St. Rank hold SPTX as of Q2 2026.

  • Citigroup held 2,454 shares of Seaport Therapeutics worth $53.3K as of Q2 2026.
  • Seaport Therapeutics was a new Citigroup position in Q2 2026.
  • Seaport Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4953 holding.
  • 5 funds tracked by Wall St. Rank held Seaport Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.